Canaan Inc. (CAN) shares rose 5.52% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $7.26 per share. In the regular
Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-market trading. The company recently granted 180-day extension by Nasdaq to regain compliance with
Trading on December 31 at the American stock markets ended in the green zone. The S&P 500 index climbed 0.64% to 3756 points, the Dow
Bionano Genomics Inc. (BNGO) stock soared 13.81% to $2.39 in the pre-market trading following an announcement from the firm that Nasdaq has granted the Company
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Ocugen Inc. (OCGN) stock soared 77.6% to $1.43 in the pre-market trading after signing a binding letter of intent (LOI) with Bharat Biotech to develop
Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under
Aethlon Medical Inc. (NASDAQ: AEMD) shares are trading down -7.08% at $2.1 at the time of writing after reporting First Patient Treated in First-in-Human Clinical
Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter
A leading supplier of high-performance computing technologies, Canaan Inc. (NASDAQ: CAN) officially revealed its unaudited financial results for the three months ended 30 September 2020.
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.